vincamine has been researched along with Innate Inflammatory Response in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Durga Veera Hanuman, D; Gadige, A; Khurana, A; Kumar Banothu, A; Kumar Bharani, K; Mahesh Kumar, J; Mekala, L; Neeradi, D; Patangrao Renushe, A | 1 |
| Abo El Gheit, RE; Badawi, GA; El-Sayed, RM | 1 |
3 other study(ies) available for vincamine and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Catharanthus; COVID-19; Cytokines; Inflammation; Interleukin-10; Lipopolysaccharides; Lung; Mice; NF-kappa B; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha; Vincamine | 2022 |
Vincamine protects against cisplatin induced nephrotoxicity via activation of Nrf2/HO-1 and hindering TLR4/ IFN-γ/CD44 cells inflammatory cascade.
Topics: Animals; Apoptosis; Cisplatin; Heme Oxygenase-1; Hyaluronan Receptors; Inflammation; Interferon-gamma; Kidney; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Signal Transduction; Toll-Like Receptor 4; Vincamine | 2021 |